PATENT CLAIM ANALYSIS

Application Number: 15757217
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "567000"]

Abstract:
The invention relates to a method of treating a dopamine related disorder in a subject, the method comprises the steps of administering therapy to a subject, the therapy comprising a plurality of doses of levodopa over a selected time period, in combination with a dopamine decarboxylase inhibitor (DDI) and a catechol-O-methyltransferase (COMT) inhibitor, wherein: (i) the dose of levodopa is lower; (ii) the dose of DDI is lower; (iii) the dosing of levodopa is less frequent; and/or (iv) the dosing of DDI is less frequent As compared with a reference regimen over the selected time period.

Claim (Index 35):
A method of treating a dopamine-related disorder comprising administering a composition manufactured according to  claim 34 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 2.08929
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15507959', '14276211', '14276235', '14789214', '12961534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7994707933341819
- 35 USC 102 Novelty (BERT): 0.6051709170705742
- Combined Prediction Score: 0.7800408057078212
- Mean Citation Score: 418.904306
- Max Citation Score: 669.4583
- Similarity Product: 447.9270377969801

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test